12:00 AM
 | 
Apr 01, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Grazax grass pollen Allergy Immunotherapy Tablet regulatory update

ALK-Abello and partner Merck said FDA accepted for review a BLA from Merck for grass pollen AIT. Merck said it expects a decision on...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >